Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Accumulated Expenses (2016 - 2025)

Iradimed (IRMD) has disclosed Accumulated Expenses for 13 consecutive years, with $3.2 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 2627.12% to $3.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.2 million through Dec 2025, up 2627.12% year-over-year, with the annual reading at $3.2 million for FY2025, 2627.12% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $3.2 million at Iradimed, up from $137025.0 in the prior quarter.
  • The five-year high for Accumulated Expenses was $3.3 million in Q3 2024, with the low at $105479.0 in Q2 2023.
  • Average Accumulated Expenses over 5 years is $1.8 million, with a median of $2.2 million recorded in 2022.
  • The sharpest move saw Accumulated Expenses skyrocketed 3025.41% in 2021, then tumbled 95.83% in 2025.
  • Over 5 years, Accumulated Expenses stood at $2.8 million in 2021, then grew by 2.04% to $2.9 million in 2022, then fell by 3.37% to $2.8 million in 2023, then crashed by 95.75% to $118000.0 in 2024, then skyrocketed by 2627.12% to $3.2 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $3.2 million, $137025.0, and $121221.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.